ACS Chemical Biology, ISSN 1554-8929, 11/2006, Volume 1, Issue 12, pp. 780 - 790
Phosphatase and tensin homologue deleted on chromosome 10 (PTEN), a phosphoinositide 3-phosphatase, is an important regulator of insulin-dependent signaling....
3T3-L1 ADIPOCYTES | LIPID PHOSPHATASES | PHOSPHOINOSITIDE PHOSPHATASE | PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY | BIOCHEMISTRY & MOLECULAR BIOLOGY | PANCREATIC BETA-CELLS | GLUCOSE-TRANSPORT | TYROSINE PHOSPHATASES | TUMOR-SUPPRESSOR PTEN | PROTEIN-KINASE B | NUCLEAR TRANSLOCATION | Fibroblasts - enzymology | Phosphorylation | Humans | Molecular Sequence Data | Adipocytes - enzymology | Structure-Activity Relationship | Adipocytes - drug effects | Dose-Response Relationship, Drug | PTEN Phosphohydrolase - antagonists & inhibitors | Drug Design | Vanadium - chemistry | Proto-Oncogene Proteins c-akt - metabolism | Binding Sites | Cell Membrane - drug effects | Amino Acid Sequence | Cell Line | PTEN Phosphohydrolase - genetics | Hypoglycemic Agents - chemistry | Hypoglycemic Agents - pharmacology | Cell Membrane - enzymology | Animals | Adipocytes - metabolism | Fibroblasts - drug effects | Glucose - metabolism | Ligands | Organometallic Compounds - chemistry | Mice | Organometallic Compounds - pharmacology
3T3-L1 ADIPOCYTES | LIPID PHOSPHATASES | PHOSPHOINOSITIDE PHOSPHATASE | PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY | BIOCHEMISTRY & MOLECULAR BIOLOGY | PANCREATIC BETA-CELLS | GLUCOSE-TRANSPORT | TYROSINE PHOSPHATASES | TUMOR-SUPPRESSOR PTEN | PROTEIN-KINASE B | NUCLEAR TRANSLOCATION | Fibroblasts - enzymology | Phosphorylation | Humans | Molecular Sequence Data | Adipocytes - enzymology | Structure-Activity Relationship | Adipocytes - drug effects | Dose-Response Relationship, Drug | PTEN Phosphohydrolase - antagonists & inhibitors | Drug Design | Vanadium - chemistry | Proto-Oncogene Proteins c-akt - metabolism | Binding Sites | Cell Membrane - drug effects | Amino Acid Sequence | Cell Line | PTEN Phosphohydrolase - genetics | Hypoglycemic Agents - chemistry | Hypoglycemic Agents - pharmacology | Cell Membrane - enzymology | Animals | Adipocytes - metabolism | Fibroblasts - drug effects | Glucose - metabolism | Ligands | Organometallic Compounds - chemistry | Mice | Organometallic Compounds - pharmacology
Journal Article
Cancer Research, ISSN 0008-5472, 09/2005, Volume 65, Issue 18, pp. 8096 - 8100
Phosphatase and tensin homologue deleted on chromosome 10 (PTEN), a tumor suppressor phosphatase that dephosphorylates both protein and lipid substrates, is...
PATHWAYS | G ARREST | PROTEIN | ONCOLOGY | PHOSPHORYLATION | KINASE | SUBCELLULAR-LOCALIZATION | BREAST | Cyclin D1 - metabolism | Phosphorylation | Down-Regulation | Humans | PTEN Phosphohydrolase - metabolism | Cytoplasm - metabolism | Intracellular Signaling Peptides and Proteins - metabolism | Phosphatidylinositol 3-Kinases - metabolism | G1 Phase - physiology | Disease Progression | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Breast Neoplasms - enzymology | Cell Nucleus - metabolism | Breast Neoplasms - pathology | Resting Phase, Cell Cycle - physiology | Cell Cycle - physiology | Cell Line, Tumor | Apoptosis - physiology | Proto-Oncogene Proteins c-akt - metabolism | Mitogen-Activated Protein Kinases - metabolism
PATHWAYS | G ARREST | PROTEIN | ONCOLOGY | PHOSPHORYLATION | KINASE | SUBCELLULAR-LOCALIZATION | BREAST | Cyclin D1 - metabolism | Phosphorylation | Down-Regulation | Humans | PTEN Phosphohydrolase - metabolism | Cytoplasm - metabolism | Intracellular Signaling Peptides and Proteins - metabolism | Phosphatidylinositol 3-Kinases - metabolism | G1 Phase - physiology | Disease Progression | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Breast Neoplasms - enzymology | Cell Nucleus - metabolism | Breast Neoplasms - pathology | Resting Phase, Cell Cycle - physiology | Cell Cycle - physiology | Cell Line, Tumor | Apoptosis - physiology | Proto-Oncogene Proteins c-akt - metabolism | Mitogen-Activated Protein Kinases - metabolism
Journal Article
Nature Cell Biology, ISSN 1465-7392, 06/2011, Volume 13, Issue 6, pp. 730 - 735
PTEN, a lipid phosphatase, is one of the most frequently mutated tumour suppressors in human cancer. Several recent studies have highlighted the importance of...
STEM-CELLS | PHOSPHATASE | PROSTATE-CANCER | TRANSCRIPTION | TUMOR-SUPPRESSOR GENE | GERMLINE MUTATIONS | CELL-SURVIVAL | BREAST | P53 | DELETION | CELL BIOLOGY | Signal Transduction | Humans | Ubiquitin-Protein Ligases - metabolism | Cell Line, Tumor | Neoplasms - enzymology | PTEN Phosphohydrolase - metabolism | Male | Neoplasms - physiopathology | Ubiquitin-Protein Ligases - physiology | Ubiquitin | Ligases | Physiological aspects | Genetic aspects | Research | Embryonic stem cells | Tumors
STEM-CELLS | PHOSPHATASE | PROSTATE-CANCER | TRANSCRIPTION | TUMOR-SUPPRESSOR GENE | GERMLINE MUTATIONS | CELL-SURVIVAL | BREAST | P53 | DELETION | CELL BIOLOGY | Signal Transduction | Humans | Ubiquitin-Protein Ligases - metabolism | Cell Line, Tumor | Neoplasms - enzymology | PTEN Phosphohydrolase - metabolism | Male | Neoplasms - physiopathology | Ubiquitin-Protein Ligases - physiology | Ubiquitin | Ligases | Physiological aspects | Genetic aspects | Research | Embryonic stem cells | Tumors
Journal Article
Nature Cell Biology, ISSN 1465-7392, 2013, Volume 15, Issue 12, pp. 1486 - 1494
The tumour suppressor PTEN is frequently lost in human cancers. In addition to gene mutations and deletions, recent studies have revealed the importance of...
BREAST-CANCER | UBIQUITINATION | CELLS | GENE | PIK3CA | PATHWAY | TUMOR-SUPPRESSOR | MUTATIONS | LIGASE | CELL BIOLOGY | Neoplasm Transplantation | Cell Proliferation | Humans | Carcinogenesis - metabolism | Breast Neoplasms - metabolism | Ubiquitination | Tumor Suppressor Proteins - genetics | HEK293 Cells | Female | Protein Stability | Proto-Oncogene Proteins c-akt - metabolism | Endopeptidases - metabolism | Gene Expression | Tumor Suppressor Proteins - metabolism | Signal Transduction | PTEN Phosphohydrolase - metabolism | Tumor Burden | Protein Transport | Carcinogenesis - pathology | Animals | Endopeptidases - genetics | Breast Neoplasms - pathology | Mice, Nude | Cell Line, Tumor | Glycolysis | Mice | Tumor suppressor genes | Research | Ubiquitin-proteasome system | Properties | Proteases | Identification and classification
BREAST-CANCER | UBIQUITINATION | CELLS | GENE | PIK3CA | PATHWAY | TUMOR-SUPPRESSOR | MUTATIONS | LIGASE | CELL BIOLOGY | Neoplasm Transplantation | Cell Proliferation | Humans | Carcinogenesis - metabolism | Breast Neoplasms - metabolism | Ubiquitination | Tumor Suppressor Proteins - genetics | HEK293 Cells | Female | Protein Stability | Proto-Oncogene Proteins c-akt - metabolism | Endopeptidases - metabolism | Gene Expression | Tumor Suppressor Proteins - metabolism | Signal Transduction | PTEN Phosphohydrolase - metabolism | Tumor Burden | Protein Transport | Carcinogenesis - pathology | Animals | Endopeptidases - genetics | Breast Neoplasms - pathology | Mice, Nude | Cell Line, Tumor | Glycolysis | Mice | Tumor suppressor genes | Research | Ubiquitin-proteasome system | Properties | Proteases | Identification and classification
Journal Article
Circulation, ISSN 0009-7322, 10/2007, Volume 116, Issue 14, pp. 1585 - 1595
Background - Oxidative stress plays a causal role in vascular injury in diabetes mellitus, but the mechanisms and targets remain poorly understood. Methods and...
Endothelium-derived factors | Hyperglycemia | Peroxynitrite | Apoptosis | Endothelium | endothelium | AORTIC ENDOTHELIAL-CELLS | CARDIAC & CARDIOVASCULAR SYSTEMS | peroxynitrite | ACTIVATED PROTEIN-KINASE | PHOSPHORYLATION | NITRIC-OXIDE SYNTHASE | apoptosis | endothelium-derived factors | hyperglycemia | HIGH GLUCOSE | TUMOR-SUPPRESSOR | INSULIN HYPERSENSITIVITY | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | TYROSINE NITRATION | EXPRESSION | Diabetes Mellitus, Experimental - drug therapy | Phosphorylation | Humans | Male | Endothelium, Vascular - enzymology | Threonine - metabolism | Hyperglycemia - drug therapy | Up-Regulation - physiology | Hyperglycemia - pathology | Diabetes Mellitus, Experimental - metabolism | Proto-Oncogene Proteins c-akt - metabolism | Umbilical Veins - cytology | Protein-Serine-Threonine Kinases - metabolism | Insulin - pharmacology | Reactive Nitrogen Species - metabolism | Cells, Cultured | PTEN Phosphohydrolase - metabolism | Serine - metabolism | Hypoglycemic Agents - pharmacology | Hyperglycemia - metabolism | Animals | Signal Transduction - drug effects | Peroxynitrous Acid - metabolism | Diabetes Mellitus, Experimental - pathology | Endothelium, Vascular - pathology | Signal Transduction - physiology | Mice | Apoptosis - physiology | Oxidative stress | Blood circulation disorders | Diabetics | Blood sugar | Physiological aspects | Research | Health aspects | Protein kinases | Risk factors
Endothelium-derived factors | Hyperglycemia | Peroxynitrite | Apoptosis | Endothelium | endothelium | AORTIC ENDOTHELIAL-CELLS | CARDIAC & CARDIOVASCULAR SYSTEMS | peroxynitrite | ACTIVATED PROTEIN-KINASE | PHOSPHORYLATION | NITRIC-OXIDE SYNTHASE | apoptosis | endothelium-derived factors | hyperglycemia | HIGH GLUCOSE | TUMOR-SUPPRESSOR | INSULIN HYPERSENSITIVITY | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | TYROSINE NITRATION | EXPRESSION | Diabetes Mellitus, Experimental - drug therapy | Phosphorylation | Humans | Male | Endothelium, Vascular - enzymology | Threonine - metabolism | Hyperglycemia - drug therapy | Up-Regulation - physiology | Hyperglycemia - pathology | Diabetes Mellitus, Experimental - metabolism | Proto-Oncogene Proteins c-akt - metabolism | Umbilical Veins - cytology | Protein-Serine-Threonine Kinases - metabolism | Insulin - pharmacology | Reactive Nitrogen Species - metabolism | Cells, Cultured | PTEN Phosphohydrolase - metabolism | Serine - metabolism | Hypoglycemic Agents - pharmacology | Hyperglycemia - metabolism | Animals | Signal Transduction - drug effects | Peroxynitrous Acid - metabolism | Diabetes Mellitus, Experimental - pathology | Endothelium, Vascular - pathology | Signal Transduction - physiology | Mice | Apoptosis - physiology | Oxidative stress | Blood circulation disorders | Diabetics | Blood sugar | Physiological aspects | Research | Health aspects | Protein kinases | Risk factors
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 09/2012, Volume 287, Issue 38, pp. 32172 - 32179
The PRL (phosphatase of regenerating liver) phosphatases are implicated in the control of cell proliferation and invasion. Aberrant PRL expression is...
INVASION | METASTASIS | CELL-MIGRATION | STABILITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMOR-SUPPRESSOR | GLYCOGEN CELLS | EXPRESSION | BINDING | TYROSINE-PHOSPHATASE | Angiogenic Proteins | Pregnancy, Animal | Cell Proliferation | Embryonic Stem Cells - cytology | Trophoblasts - metabolism | Immediate-Early Proteins - physiology | Humans | Mice, Inbred C57BL | Oncogene Proteins - metabolism | PTEN Phosphohydrolase - metabolism | Cycloheximide - pharmacology | Mice, Knockout | Placenta - metabolism | Pregnancy | Protein Tyrosine Phosphatases - genetics | Animals | Immediate-Early Proteins - genetics | Alleles | HEK293 Cells | Female | Mice | Proto-Oncogene Proteins c-akt - metabolism | Cell Movement | Protein Tyrosine Phosphatases - physiology | Protein Phosphatase | Molecular Bases of Disease | Placenta | Oncogene | PRL Phosphatases | Cell Growth | Akt | Pten | PRL2
INVASION | METASTASIS | CELL-MIGRATION | STABILITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMOR-SUPPRESSOR | GLYCOGEN CELLS | EXPRESSION | BINDING | TYROSINE-PHOSPHATASE | Angiogenic Proteins | Pregnancy, Animal | Cell Proliferation | Embryonic Stem Cells - cytology | Trophoblasts - metabolism | Immediate-Early Proteins - physiology | Humans | Mice, Inbred C57BL | Oncogene Proteins - metabolism | PTEN Phosphohydrolase - metabolism | Cycloheximide - pharmacology | Mice, Knockout | Placenta - metabolism | Pregnancy | Protein Tyrosine Phosphatases - genetics | Animals | Immediate-Early Proteins - genetics | Alleles | HEK293 Cells | Female | Mice | Proto-Oncogene Proteins c-akt - metabolism | Cell Movement | Protein Tyrosine Phosphatases - physiology | Protein Phosphatase | Molecular Bases of Disease | Placenta | Oncogene | PRL Phosphatases | Cell Growth | Akt | Pten | PRL2
Journal Article
Cancer Research, ISSN 0008-5472, 05/2005, Volume 65, Issue 10, pp. 4108 - 4116
Although phosphatase and tensin homologue deleted on chromosome 10 (PTEN) localization in the nucleus and cytoplasm is established, the mechanism is unknown....
DOMAIN | TRANSPORT | MELANOMA | GENE | MECHANISM | ONCOLOGY | TUMOR-SUPPRESSOR | CELL-CYCLE ARREST | EXPRESSION | BREAST | P53 | Phosphoric Monoester Hydrolases - genetics | Phosphorylation | Tumor Suppressor Proteins - metabolism | Mutagenesis, Site-Directed | Nuclear Localization Signals - genetics | Humans | Nuclear Localization Signals - metabolism | Cytoplasm - metabolism | Structure-Activity Relationship | Breast Neoplasms - metabolism | Breast Neoplasms - genetics | Cell Nucleus - metabolism | Karyopherins - metabolism | Transfection | Cell Nucleus - genetics | PTEN Phosphohydrolase | Tumor Suppressor Proteins - genetics | Vault Ribonucleoprotein Particles - metabolism | Cell Line, Tumor | Mutation | Phosphoric Monoester Hydrolases - metabolism
DOMAIN | TRANSPORT | MELANOMA | GENE | MECHANISM | ONCOLOGY | TUMOR-SUPPRESSOR | CELL-CYCLE ARREST | EXPRESSION | BREAST | P53 | Phosphoric Monoester Hydrolases - genetics | Phosphorylation | Tumor Suppressor Proteins - metabolism | Mutagenesis, Site-Directed | Nuclear Localization Signals - genetics | Humans | Nuclear Localization Signals - metabolism | Cytoplasm - metabolism | Structure-Activity Relationship | Breast Neoplasms - metabolism | Breast Neoplasms - genetics | Cell Nucleus - metabolism | Karyopherins - metabolism | Transfection | Cell Nucleus - genetics | PTEN Phosphohydrolase | Tumor Suppressor Proteins - genetics | Vault Ribonucleoprotein Particles - metabolism | Cell Line, Tumor | Mutation | Phosphoric Monoester Hydrolases - metabolism
Journal Article
BMC Cancer, ISSN 1471-2407, 08/2008, Volume 8, Issue 1, pp. 234 - 234
Background: The epidermal growth factor receptor (EGFR) is over-expressed in 70-75% of colorectal adenocarcinomas (CRC). The anti-EGFR monoclonal antibody...
ONCOLOGY | EPIDERMAL-GROWTH-FACTOR | KRAS MUTATION | IN-SITU HYBRIDIZATION | PHASE-II | GENE AMPLIFICATION | FACTOR RECEPTOR EXPRESSION | MOLECULAR DETERMINANTS | KINASE INHIBITORS | CARCINOMA | EGFR | Colorectal Neoplasms - mortality | PTEN Phosphohydrolase - genetics | Predictive Value of Tests | Colorectal Neoplasms - enzymology | Adenocarcinoma - pathology | Humans | Middle Aged | Adenocarcinoma - enzymology | Antibodies, Monoclonal - therapeutic use | In Situ Hybridization, Fluorescence | Male | Survival Rate | Antineoplastic Agents - therapeutic use | Adenocarcinoma - drug therapy | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Colorectal Neoplasms - drug therapy | Gene Deletion | Adult | Female | Aged | Cetuximab | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Physiological aspects | Diagnosis | Drug therapy | Identification and classification | Oncogenes | Colorectal cancer
ONCOLOGY | EPIDERMAL-GROWTH-FACTOR | KRAS MUTATION | IN-SITU HYBRIDIZATION | PHASE-II | GENE AMPLIFICATION | FACTOR RECEPTOR EXPRESSION | MOLECULAR DETERMINANTS | KINASE INHIBITORS | CARCINOMA | EGFR | Colorectal Neoplasms - mortality | PTEN Phosphohydrolase - genetics | Predictive Value of Tests | Colorectal Neoplasms - enzymology | Adenocarcinoma - pathology | Humans | Middle Aged | Adenocarcinoma - enzymology | Antibodies, Monoclonal - therapeutic use | In Situ Hybridization, Fluorescence | Male | Survival Rate | Antineoplastic Agents - therapeutic use | Adenocarcinoma - drug therapy | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Colorectal Neoplasms - drug therapy | Gene Deletion | Adult | Female | Aged | Cetuximab | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Physiological aspects | Diagnosis | Drug therapy | Identification and classification | Oncogenes | Colorectal cancer
Journal Article
BMC Cancer, ISSN 1471-2407, 11/2012, Volume 12, Issue 1, pp. 543 - 543
Background: Prostate cancer (PCa), a leading cause of cancer death in North American men, displays a broad range of clinical outcome from relatively indolent...
PTEN | Prostate cancer | Prognosis | ANDROGEN RECEPTOR | CELLS | RESPONSIVENESS | IN-SITU HYBRIDIZATION | FISH ANALYSIS | RADICAL PROSTATECTOMY | CASTRATION | GENE | ONCOLOGY | TUMOR-SUPPRESSOR | PROGRESSION | PTEN Phosphohydrolase - genetics | Prostatic Neoplasms - pathology | Sequence Deletion | Gene Expression | Genetic Predisposition to Disease | Follow-Up Studies | Signal Transduction | Humans | Middle Aged | Transcriptional Activation | Kaplan-Meier Estimate | Male | DNA Copy Number Variations | Neoplasm Recurrence, Local - pathology | Prostatic Neoplasms - genetics | Receptors, Androgen - genetics | Receptors, Androgen - biosynthesis | Neoplasm Recurrence, Local - genetics | Transcription, Genetic | Aged | Immunohistochemistry | Usage | Physiological aspects | Genetic aspects | Cellular signal transduction | Diagnosis | Research | Protein kinases | AR
PTEN | Prostate cancer | Prognosis | ANDROGEN RECEPTOR | CELLS | RESPONSIVENESS | IN-SITU HYBRIDIZATION | FISH ANALYSIS | RADICAL PROSTATECTOMY | CASTRATION | GENE | ONCOLOGY | TUMOR-SUPPRESSOR | PROGRESSION | PTEN Phosphohydrolase - genetics | Prostatic Neoplasms - pathology | Sequence Deletion | Gene Expression | Genetic Predisposition to Disease | Follow-Up Studies | Signal Transduction | Humans | Middle Aged | Transcriptional Activation | Kaplan-Meier Estimate | Male | DNA Copy Number Variations | Neoplasm Recurrence, Local - pathology | Prostatic Neoplasms - genetics | Receptors, Androgen - genetics | Receptors, Androgen - biosynthesis | Neoplasm Recurrence, Local - genetics | Transcription, Genetic | Aged | Immunohistochemistry | Usage | Physiological aspects | Genetic aspects | Cellular signal transduction | Diagnosis | Research | Protein kinases | AR
Journal Article
BMC Medical Genomics, ISSN 1755-8794, 11/2017, Volume 10, Issue 1, pp. 64 - 8
Background: MiRNAs are frequently abnormally expressed in the progression of human osteosarcoma. Phosphatase and tensin homologue deleted on chromosome 10...
MiR-30a | PTEN | Anti-tumor | Osteosarcoma | MIRNA | GENETICS & HEREDITY | TUMOR-GROWTH | CARCINOMA | Genetic aspects | MicroRNA | Research | Gene expression
MiR-30a | PTEN | Anti-tumor | Osteosarcoma | MIRNA | GENETICS & HEREDITY | TUMOR-GROWTH | CARCINOMA | Genetic aspects | MicroRNA | Research | Gene expression
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 12/2007, Volume 152, Issue 8, pp. 1172 - 1184
Background and purpose: Epithelial injury contributes to lung pathogenesis. Our work and that of others have identified the phosphoinositide‐3 kinase...
lung | PTEN | epithelium | wound remodelling | Wound remodelling | Epithelium | Lung | CELLS | ACTIVATION | FREQUENT | PROTEIN | KINASE | TUMOR-SUPPRESSOR PTEN | CANCER | INHIBITION | GROWTH | PHARMACOLOGY & PHARMACY | EXPRESSION | L-Lactate Dehydrogenase - metabolism | PTEN Phosphohydrolase - drug effects | Phosphorylation | Epithelial Cells - drug effects | Humans | Phosphatidylinositol 3-Kinases - metabolism | Lung - cytology | L-Lactate Dehydrogenase - drug effects | Drug Delivery Systems | Dose-Response Relationship, Drug | Protein Tyrosine Phosphatases - antagonists & inhibitors | Phenanthrolines - pharmacology | Phenanthrolines - administration & dosage | Time Factors | Phosphatidylinositol 3-Kinases - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Wound Healing - drug effects | Cell Line | Lung - pathology | Signal Transduction | Organometallic Compounds - adverse effects | Epithelial Cells - pathology | Glucose-6-Phosphatase - antagonists & inhibitors | Lung - drug effects | Wound Healing - physiology | Phenanthrolines - adverse effects | Organometallic Compounds - pharmacology | Organometallic Compounds - administration & dosage | Proto-Oncogene Proteins c-akt - drug effects | Research Papers
lung | PTEN | epithelium | wound remodelling | Wound remodelling | Epithelium | Lung | CELLS | ACTIVATION | FREQUENT | PROTEIN | KINASE | TUMOR-SUPPRESSOR PTEN | CANCER | INHIBITION | GROWTH | PHARMACOLOGY & PHARMACY | EXPRESSION | L-Lactate Dehydrogenase - metabolism | PTEN Phosphohydrolase - drug effects | Phosphorylation | Epithelial Cells - drug effects | Humans | Phosphatidylinositol 3-Kinases - metabolism | Lung - cytology | L-Lactate Dehydrogenase - drug effects | Drug Delivery Systems | Dose-Response Relationship, Drug | Protein Tyrosine Phosphatases - antagonists & inhibitors | Phenanthrolines - pharmacology | Phenanthrolines - administration & dosage | Time Factors | Phosphatidylinositol 3-Kinases - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Wound Healing - drug effects | Cell Line | Lung - pathology | Signal Transduction | Organometallic Compounds - adverse effects | Epithelial Cells - pathology | Glucose-6-Phosphatase - antagonists & inhibitors | Lung - drug effects | Wound Healing - physiology | Phenanthrolines - adverse effects | Organometallic Compounds - pharmacology | Organometallic Compounds - administration & dosage | Proto-Oncogene Proteins c-akt - drug effects | Research Papers
Journal Article
Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, 2007, Volume 103, Issue 2, pp. 196 - 199
PTEN phosphatase, a product of PTEN tumor suppressor gene, exists in cells in phosphorylated and unphosphorylated form and has a central role in regulation of...
Leiomyoma | Enhanced PTEN phosphorylation | Impaired PTEN/Akt signalling | impaired PTEN/Akt signalling | ACTIVATION | enhanced PTEN phosphorylation | BIOCHEMISTRY & MOLECULAR BIOLOGY | GROWTH | ENDOCRINOLOGY & METABOLISM | MYOMETRIUM | AKT/PROTEIN KINASE-B | HUMAN LEIOMYOMA | EXPRESSION | leiomyoma | ESTROGEN-RECEPTOR | Protein Kinases - metabolism | Gene Expression | Phosphorylation | Uterine Neoplasms - metabolism | Humans | Middle Aged | PTEN Phosphohydrolase - metabolism | Adult | Female | Leiomyoma - metabolism | Oncogene Protein v-akt - metabolism | Case-Control Studies | Proteins | Genetic research | Physiological aspects
Leiomyoma | Enhanced PTEN phosphorylation | Impaired PTEN/Akt signalling | impaired PTEN/Akt signalling | ACTIVATION | enhanced PTEN phosphorylation | BIOCHEMISTRY & MOLECULAR BIOLOGY | GROWTH | ENDOCRINOLOGY & METABOLISM | MYOMETRIUM | AKT/PROTEIN KINASE-B | HUMAN LEIOMYOMA | EXPRESSION | leiomyoma | ESTROGEN-RECEPTOR | Protein Kinases - metabolism | Gene Expression | Phosphorylation | Uterine Neoplasms - metabolism | Humans | Middle Aged | PTEN Phosphohydrolase - metabolism | Adult | Female | Leiomyoma - metabolism | Oncogene Protein v-akt - metabolism | Case-Control Studies | Proteins | Genetic research | Physiological aspects
Journal Article
摘要 PTEN (phosphatase and Tensin homolog deleted on chromosome 10,亦稱MMAC1 or TEP1)為一種磷酸酶,擷抗磷脂酰肌醇激酶(PI3K;phosphoinositide 3-kinase)所引起的生理活性。內皮分化因子(Endothlial...
鹼性纖維母細胞 | endothelial cells | 生長因子補充劑 | gas glands | insulin | 類胰島素生長因子 | EDF-1 | PTEN | IGF-1 | bFGF | 過氧化體增殖劑活化受器 | PI3K | PPAR | 睪固酮 | 胰島素增敏劑 | steroids | 卵巢發育指數 | GSI | 紅體發育指數
鹼性纖維母細胞 | endothelial cells | 生長因子補充劑 | gas glands | insulin | 類胰島素生長因子 | EDF-1 | PTEN | IGF-1 | bFGF | 過氧化體增殖劑活化受器 | PI3K | PPAR | 睪固酮 | 胰島素增敏劑 | steroids | 卵巢發育指數 | GSI | 紅體發育指數
Dissertation
The FEBS Journal, ISSN 1742-464X, 01/2014, Volume 281, Issue 1, pp. 88 - 103
Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has been reported to play a role in the suppression of activated hepatic stellate cells...
DNA methylation | microRNA‐29b | DNA methyltransferase | hepatic stellate cells | phosphatase and tensin homologue deleted on chromosome 10 | microRNA-29b | ACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | RECEPTOR | IN-VITRO | INHIBITION | METHYLTRANSFERASES | GROWTH | TUMORIGENESIS | EXPRESSION | PROGRESSION | RNA, Small Interfering - genetics | Luciferases - metabolism | Apoptosis - drug effects | Humans | Male | DNA (Cytosine-5-)-Methyltransferases - antagonists & inhibitors | Liver Cirrhosis - chemically induced | Proto-Oncogene Proteins c-akt - genetics | DNA (Cytosine-5-)-Methyltransferases - metabolism | PTEN Phosphohydrolase - antagonists & inhibitors | Antineoplastic Agents - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Liver Cirrhosis - genetics | Real-Time Polymerase Chain Reaction | Hepatic Stellate Cells - pathology | Hepatic Stellate Cells - drug effects | Chromosome Deletion | PTEN Phosphohydrolase - genetics | Promoter Regions, Genetic | Liver Cirrhosis - prevention & control | RNA, Messenger - genetics | Cells, Cultured | Curcumin - pharmacology | Gene Expression Regulation | PTEN Phosphohydrolase - metabolism | Rats | Carbon Tetrachloride - toxicity | Reverse Transcriptase Polymerase Chain Reaction | Rats, Sprague-Dawley | Blotting, Western | DNA (Cytosine-5-)-Methyltransferases - genetics | Animals | Cell Proliferation - drug effects | MicroRNAs - genetics | Chromosomes, Human, Pair 10 - genetics | DNA Methylation - drug effects | Liver diseases | Phosphatases | MicroRNA | Liver | DNA | Fibrosis | Genetic research | Genetic transcription | Methylation | Epigenetics | MicroRNAs | Apoptosis
DNA methylation | microRNA‐29b | DNA methyltransferase | hepatic stellate cells | phosphatase and tensin homologue deleted on chromosome 10 | microRNA-29b | ACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | RECEPTOR | IN-VITRO | INHIBITION | METHYLTRANSFERASES | GROWTH | TUMORIGENESIS | EXPRESSION | PROGRESSION | RNA, Small Interfering - genetics | Luciferases - metabolism | Apoptosis - drug effects | Humans | Male | DNA (Cytosine-5-)-Methyltransferases - antagonists & inhibitors | Liver Cirrhosis - chemically induced | Proto-Oncogene Proteins c-akt - genetics | DNA (Cytosine-5-)-Methyltransferases - metabolism | PTEN Phosphohydrolase - antagonists & inhibitors | Antineoplastic Agents - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Liver Cirrhosis - genetics | Real-Time Polymerase Chain Reaction | Hepatic Stellate Cells - pathology | Hepatic Stellate Cells - drug effects | Chromosome Deletion | PTEN Phosphohydrolase - genetics | Promoter Regions, Genetic | Liver Cirrhosis - prevention & control | RNA, Messenger - genetics | Cells, Cultured | Curcumin - pharmacology | Gene Expression Regulation | PTEN Phosphohydrolase - metabolism | Rats | Carbon Tetrachloride - toxicity | Reverse Transcriptase Polymerase Chain Reaction | Rats, Sprague-Dawley | Blotting, Western | DNA (Cytosine-5-)-Methyltransferases - genetics | Animals | Cell Proliferation - drug effects | MicroRNAs - genetics | Chromosomes, Human, Pair 10 - genetics | DNA Methylation - drug effects | Liver diseases | Phosphatases | MicroRNA | Liver | DNA | Fibrosis | Genetic research | Genetic transcription | Methylation | Epigenetics | MicroRNAs | Apoptosis
Journal Article
Cancer Research, ISSN 0008-5472, 05/2009, Volume 69, Issue 10, pp. 4192 - 4201
Knockdown of the tumor suppressor phosphatase Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) with shRNA in three estrogen receptor...
ACTIVATED PROTEIN-KINASE | PIK3CA MUTATIONS | ONCOLOGY | CELL-MIGRATION | TYROSINE KINASE | GENE-EXPRESSION | PROGESTERONE-RECEPTOR | TUMOR-SUPPRESSOR PTEN | 26S PROTEASOME | VIVO ANTITUMOR-ACTIVITY | ESTROGEN-RECEPTOR | Chromosome Deletion | PTEN Phosphohydrolase - deficiency | Humans | Drug Resistance, Neoplasm | Receptor, ErbB-2 - physiology | Receptor, ErbB-3 - physiology | Chromosomes, Human, Pair 19 | Estrogen Receptor Modulators - therapeutic use | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Cell Division | Receptor, IGF Type 1 - physiology | Cell Line, Tumor | Female | Transcription, Genetic | Genes, Reporter | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
ACTIVATED PROTEIN-KINASE | PIK3CA MUTATIONS | ONCOLOGY | CELL-MIGRATION | TYROSINE KINASE | GENE-EXPRESSION | PROGESTERONE-RECEPTOR | TUMOR-SUPPRESSOR PTEN | 26S PROTEASOME | VIVO ANTITUMOR-ACTIVITY | ESTROGEN-RECEPTOR | Chromosome Deletion | PTEN Phosphohydrolase - deficiency | Humans | Drug Resistance, Neoplasm | Receptor, ErbB-2 - physiology | Receptor, ErbB-3 - physiology | Chromosomes, Human, Pair 19 | Estrogen Receptor Modulators - therapeutic use | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Cell Division | Receptor, IGF Type 1 - physiology | Cell Line, Tumor | Female | Transcription, Genetic | Genes, Reporter | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Cancer Research, ISSN 0008-5472, 02/2007, Volume 67, Issue 3, pp. 1170 - 1175
Trastuzumab antitumor activity in ErbB2-overexpressing breast cancers seems to be dependent upon the presence of phosphatase and tensin homologue deleted on...
CELLS | TRASTUZUMAB | ONCOLOGY | ERBB2 TYROSINE KINASES | GW572016 | PTEN | CARCINOMAS | EGFR/ERBB2 | AKT | INHIBITOR | TUMOR-GROWTH | PTEN Phosphohydrolase - genetics | PTEN Phosphohydrolase - deficiency | Phosphorylation | Receptor, ErbB-2 - biosynthesis | Apoptosis - drug effects | Humans | Receptor, ErbB-2 - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Breast Neoplasms - drug therapy | Breast Neoplasms - enzymology | Breast Neoplasms - genetics | Signal Transduction - drug effects | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Receptor, ErbB-2 - antagonists & inhibitors | Apoptosis - physiology | Proto-Oncogene Proteins c-akt - metabolism | Quinazolines - pharmacology
CELLS | TRASTUZUMAB | ONCOLOGY | ERBB2 TYROSINE KINASES | GW572016 | PTEN | CARCINOMAS | EGFR/ERBB2 | AKT | INHIBITOR | TUMOR-GROWTH | PTEN Phosphohydrolase - genetics | PTEN Phosphohydrolase - deficiency | Phosphorylation | Receptor, ErbB-2 - biosynthesis | Apoptosis - drug effects | Humans | Receptor, ErbB-2 - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Breast Neoplasms - drug therapy | Breast Neoplasms - enzymology | Breast Neoplasms - genetics | Signal Transduction - drug effects | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Receptor, ErbB-2 - antagonists & inhibitors | Apoptosis - physiology | Proto-Oncogene Proteins c-akt - metabolism | Quinazolines - pharmacology
Journal Article
2007
PTEN is a tumour suppressor protein named after its homology with phosphatase and tensin and its frequent deletion on chromosome 10. PTEN was discovered to be...
Dissertation